Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PTIXW PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM)

Watchlist
0.070
+0.029+70.73%
Close  02/03 16:00 ET
High
0.080
Open
0.071
Turnover
892.00
Low
0.063
Pre Close
0.041
Volume
11.83K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.310
Shares
0
P/E(Static)
0.00
52wk Low
0.010
Float Cap
0
Bid/Ask %
67.59%
Historical High
0.800
Shs Float
0
Volume Ratio
4.98
Historical Low
0.010
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
40.78%
Avg Price
0.075
Lot Size
1
Float Cap
0
Bid/Ask %
67.59%
Historical High
0.800
Shs Float
0
Volume Ratio
4.98
Historical Low
0.010
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
40.78%
Avg Price
0.075
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Listing Date: 04/27/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist